Incidence and risk factors for clozapine-induced myocarditis and cardiomyopathy at a regional mental health service in Australia

Overview of attention for article published in Australasian Psychiatry, September 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source

facebook: 1 Facebook page

Citations

dimensions_citation: 47 Dimensions

Readers on

mendeley: 40 Mendeley

Summary News Policy documents Facebook Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Monitoring Patients With Psychotic Disorders for Clozapine-Induced Myocarditis or Cardiomyopathy

Cited by Canadian Agency for Drugs and Technologies in Health on 01 Jun 2022

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Clozapine Initiation for Schizophrenia: A Review of Clinical Effectiveness and Guidelines

Cited by Canadian Agency for Drugs and Technologies in Health on 28 Jan 2020

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.